Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030 Ruchika Sharma13 Dec 2022 12:13 PM ISTNew York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 years Ruchika Sharma6 Dec 2022 11:30 AM ISTNew York: Pfizer and BioNTech have announced that the companies have submitted an application to the U.S. Food and Drug Administration (USFDA) for...
BioNTech, Ryvu Therapeutics ink pact for Immuno-Modulatory Small Molecule Candidates Ruchika Sharma4 Dec 2022 12:30 PM ISTUnder the terms of the agreement, BioNTech will pay Ryvu an upfront fee of €20 million in exchange for certain rights to Ryvu’s STING agonist...
BioNTech affiliate to acquire Novartis GMP-certified manufacturing facility in Singapore Ruchika Sharma15 Nov 2022 4:32 PM ISTSingapore: BioNTech SE has announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement...
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU Ruchika Sharma13 Nov 2022 2:00 PM IST-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Pfizer-BioNTech to test combined COVID, influenza vaccine Ruchika Sharma4 Nov 2022 3:40 PM ISTFrankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...
Pfizer, BioNTech report positive early data from clinical trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in 18 years and older Ruchika Sharma16 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced early data from a Phase 2/3 clinical trial evaluating the safety, tolerability, and...
Pfizer gets USFDA Emergency Use Authorization for bivalent omicron booster in children aged 5 through 11 years Ruchika Sharma13 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization...
BioNTech, Australia collaborate to establish mRNA Research Center Ruchika Sharma9 Oct 2022 10:00 AM ISTAustralia: BioNTech SE has announced that the company has agreed a Letter of Intent with the State of Victoria in Australia on a strategic...
